Moreover, flow cytometry analysis of stem cell surface markers commonly used for isolating liver cancer stem cells demonstrated that, while expression of CD44 and CD90 remained unchanged upon Dox treatment, EpCAM + cell population significantly increased in both Dox‐treated LCSCs and nonstem cells (Fig. S3, Fig 2B). This evidence concerns the gene EPCAM and liver cancer.